IBIO
iBio, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$72.89M
P/E Ratio
—
EPS
$-1.04
Beta
1.36
52W High
$3.82
52W Low
$0.56
50-Day MA
$2.31
200-Day MA
$1.45
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About iBio, Inc. Common Stock
iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | 300,000 |
| Gross Profit (TTM) | 300,000 |
| EBITDA | $-24.74M |
| Operating Margin | -8491.00% |
| Return on Equity | -70.20% |
| Return on Assets | -37.00% |
| Revenue/Share (TTM) | $0.02 |
| Book Value | $1.88 |
| Price-to-Book | 1.21 |
| Price-to-Sales (TTM) | 242.96 |
| EV/Revenue | 60.49 |
| EV/EBITDA | -1.59 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 14.30% |
| Shares Outstanding | $34.54M |
| Float | $27.01M |
| % Insiders | 2.46% |
| % Institutions | 51.54% |
Analyst Ratings
Consensus ($5.37 target)
6
BuyData last updated: 4/8/2026